QA: Evofem Biosciences Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001618835_2020_Evofem_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001618835, Evofem Biosciences Inc

  xvar xval
0 AssetsCurrent 26,421,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 394,000
3 remainder_Assets 1,480,000
4 LiabilitiesCurrent 12,659,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,107,588
9 ResearchAndDevelopmentExpense 16,451,445
10 remainder_Expenses 3,983
11 remainder_Revenues 0
12 remainder_NetIncome -22,140,300
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 28,295,000
1 Liabilities 12,659,000
2 Expenses 41,563,016
3 Revenues 0
4 StockholdersEquity 15,636,000
5 NetIncome -63,703,316
6 ComprehensiveNetIncome -63,703,316
7 BaseVar 52,328,658
8 EconomicCapitalRatiobeforeLimitedLiability -1.45
9 EconomicCapitalRatio 1.19

Edgar->Model Mapping

Feature Distribution

Change over Time